WallStreetZenWallStreetZen

NASDAQ: BIOR
Biora Therapeutics Inc Stock Ownership - Who owns Biora Therapeutics?

Insider buying vs selling

Have Biora Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eric DesparbesChief Financial Officer2024-08-1527,830$0.67
$18.65kSell
Aditya P. MohantyChief Executive Officer2024-08-1570,883$0.67
$47.49kSell
Clarke NeumannOfficer2024-08-1526,629$0.67
$17.84kSell

1 of 1

BIOR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIOR insiders and whales buy or sell their stock.

BIOR Shareholders

What type of owners hold Biora Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Athyrium Capital Management LP99.80%36,396,907$20.09MInsider
Athyrium Opportunities Fund A LP99.80%36,396,907$20.09MInsider
Harry Stylli40.63%14,816,522$8.18MInsider
Athyrium Opportunities Iii Coinvest 1 LP29.97%10,929,763$6.03MInsider
Athyrium Capital Management LP29.97%10,929,762$6.03MInstitution
Aditya P. Mohanty4.03%1,468,609$810.67kInsider
Vanguard Group Inc1.91%697,330$384.93kInstitution
Eric Desparbes1.58%575,832$317.86kInsider
Clarke Neumann1.28%465,564$256.99kInsider
Damon Silvestry0.80%291,499$160.91kInsider

1 of 3

BIOR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIOR10.71%89.29%Net SellingNet Selling
NRXS1.62%38.91%Net Buying
SPRB40.13%44.72%Net Selling
MNPR2.17%97.83%Net BuyingNet Selling
NRSN9.26%0.00%

Biora Therapeutics Stock Ownership FAQ

Who owns Biora Therapeutics?

Biora Therapeutics (NASDAQ: BIOR) is owned by 33.53% institutional shareholders, 279.50% Biora Therapeutics insiders, and 0.00% retail investors. Athyrium Capital Management LP is the largest individual Biora Therapeutics shareholder, owning 36.40M shares representing 99.80% of the company. Athyrium Capital Management LP's Biora Therapeutics shares are currently valued at $19.18M.

If you're new to stock investing, here's how to buy Biora Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.